The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. However, current AP developments are mainly hybrid closed-loop systems that include feed-forward actions triggered by the announcement of meals or exercise. The first step to fully closing the loop in the AP requires removing meal announcement, which is currently the most effective way to alleviate postprandial hyperglycemia due to the delay in insulin action. Here, a novel approach to meal detection in the AP is presented using a sliding window and computing the normalized cross-covariance between measured glucose and the forward ...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
International audienceThis study aims at developing an unannounced meal detection method for artific...
Background and Objective Current prototypes of closed-loop systems for glucose control in type 1 dia...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
© 2021 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for a...
Background: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal ann...
The integration of subcutaneous sensing and insulin delivery technologies with novel control strateg...
Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
The first attempts for automated glucose control were made in the seventies of the last century. Now...
Meals are one of the greatest challenges to glucose regulation in diabetes mellitus type 1. Several ...
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin p...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
International audienceThis study aims at developing an unannounced meal detection method for artific...
Background and Objective Current prototypes of closed-loop systems for glucose control in type 1 dia...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
© 2021 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for a...
Background: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal ann...
The integration of subcutaneous sensing and insulin delivery technologies with novel control strateg...
Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
The first attempts for automated glucose control were made in the seventies of the last century. Now...
Meals are one of the greatest challenges to glucose regulation in diabetes mellitus type 1. Several ...
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin p...
Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose control in dia...
International audienceThis study aims at developing an unannounced meal detection method for artific...
Background and Objective Current prototypes of closed-loop systems for glucose control in type 1 dia...